APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Alcoholic Liver Diseases Treatment

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Alcoholic Liver Diseases Treatment Market Outlook and Growth Opportunities 2026

19 December 2025194 pages

Choose your research edition.

Industry ResearchAlcoholic Liver Diseases Treatment Industry Research Report 2026112 pages · $2,950 USDIndustry Growth & TrendsGlobal Alcoholic Liver Diseases Treatment Industry Growth and Trends Forecast to 203289 pages · $3,450 USDMarket StructureGlobal Alcoholic Liver Diseases Treatment Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032183 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Alcoholic Liver Diseases Treatment Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Alcoholic Liver Diseases Treatment Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Alcoholic Liver Diseases Treatment market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Alcoholic Liver Diseases Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Alcoholic Liver Diseases Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Alcoholic Liver Diseases Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Alcoholic Liver Diseases Treatment market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Alcoholic Liver Diseases Treatment market include Roche Holding, Upsher-Smith Laboratories, Bayer, GlaxoSmithKline, Pfizer, Novartis, Johnson & Johnson Services and Sanofi, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Alcoholic Liver Diseases Treatment market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Alcoholic Liver Diseases Treatment and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Alcoholic Liver Diseases Treatment revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Alcoholic Liver Diseases Treatment market.

Alcoholic Liver Diseases Treatment Segment by Company

Roche Holding

Upsher-Smith Laboratories

Bayer

GlaxoSmithKline

Pfizer

Novartis

Johnson & Johnson Services

Sanofi

Alcoholic Liver Diseases Treatment Segment by Type

Alcoholic Fatty Liver Disease

Alcoholic Liver Hepatitis

Others

Alcoholic Liver Diseases Treatment Segment by Application

Hospital Pharmacies

Drug Stores

Online Pharmacies

Retail Pharmacies

Others

Alcoholic Liver Diseases Treatment Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Alcoholic Liver Diseases Treatment status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Alcoholic Liver Diseases Treatment key companies, revenue, market share, and recent developments.

3. To split the Alcoholic Liver Diseases Treatment breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Alcoholic Liver Diseases Treatment market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Alcoholic Liver Diseases Treatment significant trends, drivers, influence factors in global and regions.

6. To analyze Alcoholic Liver Diseases Treatment competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Alcoholic Liver Diseases Treatment market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Alcoholic Liver Diseases Treatment and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Alcoholic Liver Diseases Treatment.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Alcoholic Liver Diseases Treatment industry.

Chapter 3: Detailed analysis of Alcoholic Liver Diseases Treatment company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Alcoholic Liver Diseases Treatment in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Alcoholic Liver Diseases Treatment in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Alcoholic Liver Diseases Treatment Industry Trends Table 2. Alcoholic Liver Diseases Treatment Industry Drivers Table 3. Alcoholic Liver Diseases Treatment Industry Opportunities and Challenges Table 4. Alcoholic Liver Diseases Treatment Industry Restraints Table 5. Global Alcoholic Liver Diseases Treatment Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Alcoholic Liver Diseases Treatment Revenue Share by Company (2021-2026) Table 7. Global Alcoholic Liver Diseases Treatment Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Alcoholic Liver Diseases Treatment Key Company Manufacturing Base & Headquarters Table 9. Global Alcoholic Liver Diseases Treatment Company, Product Type & Application Table 10. Global Alcoholic Liver Diseases Treatment Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Alcoholic Liver Diseases Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Alcoholic Fatty Liver Disease Table 15. Significant Companies of Alcoholic Liver Hepatitis Table 16. Significant Companies of Others Table 17. Global Alcoholic Liver Diseases Treatment Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 18. Global Alcoholic Liver Diseases Treatment Sales Value by Type (2021-2026) & (US$ Million) Table 19. Global Alcoholic Liver Diseases Treatment Sales Value by Type (2027-2032) & (US$ Million) Table 20. Global Alcoholic Liver Diseases Treatment Sales Value Share by Type (2021-2026) Table 21. Global Alcoholic Liver Diseases Treatment Sales Value Share by Type (2027-2032) Table 22. Significant Companies of Hospital Pharmacies Table 23. Significant Companies of Drug Stores Table 24. Significant Companies of Online Pharmacies Table 25. Significant Companies of Retail Pharmacies Table 26. Significant Companies of Others Table 27. Global Alcoholic Liver Diseases Treatment Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Alcoholic Liver Diseases Treatment Sales Value by Application (2021-2026) & (US$ Million) Table 29. Global Alcoholic Liver Diseases Treatment Sales Value by Application (2027-2032) & (US$ Million) Table 30. Global Alcoholic Liver Diseases Treatment Sales Value Share by Application (2021-2026) Table 31. Global Alcoholic Liver Diseases Treatment Sales Value Share by Application (2027-2032) Table 32. Global Alcoholic Liver Diseases Treatment Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Alcoholic Liver Diseases Treatment Sales Value by Region (2021-2026) & (US$ Million) Table 34. Global Alcoholic Liver Diseases Treatment Sales Value Share by Region (2021-2026) Table 35. Global Alcoholic Liver Diseases Treatment Sales Value by Region (2027-2032) & (US$ Million) Table 36. Global Alcoholic Liver Diseases Treatment Sales Value Share by Region (2027-2032) Table 37. Global Alcoholic Liver Diseases Treatment Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Alcoholic Liver Diseases Treatment Sales Value by Country (2021-2026) & (US$ Million) Table 39. Global Alcoholic Liver Diseases Treatment Sales Value Market Share by Country (2021-2026) Table 40. Global Alcoholic Liver Diseases Treatment Sales Value by Country (2027-2032) & (US$ Million) Table 41. Global Alcoholic Liver Diseases Treatment Sales Value Market Share by Country (2027-2032) Table 42. Roche Holding Company Information Table 43. Roche Holding Business Overview Table 44. Roche Holding Alcoholic Liver Diseases Treatment Revenue (US$ Million) and Gross Margin (2021-2026) Table 45. Roche Holding Alcoholic Liver Diseases Treatment Product Portfolio Table 46. Roche Holding Recent Development Table 47. Upsher-Smith Laboratories Company Information Table 48. Upsher-Smith Laboratories Business Overview Table 49. Upsher-Smith Laboratories Alcoholic Liver Diseases Treatment Revenue (US$ Million) and Gross Margin (2021-2026) Table 50. Upsher-Smith Laboratories Alcoholic Liver Diseases Treatment Product Portfolio Table 51. Upsher-Smith Laboratories Recent Development Table 52. Bayer Company Information Table 53. Bayer Business Overview Table 54. Bayer Alcoholic Liver Diseases Treatment Revenue (US$ Million) and Gross Margin (2021-2026) Table 55. Bayer Alcoholic Liver Diseases Treatment Product Portfolio Table 56. Bayer Recent Development Table 57. GlaxoSmithKline Company Information Table 58. GlaxoSmithKline Business Overview Table 59. GlaxoSmithKline Alcoholic Liver Diseases Treatment Revenue (US$ Million) and Gross Margin (2021-2026) Table 60. GlaxoSmithKline Alcoholic Liver Diseases Treatment Product Portfolio Table 61. GlaxoSmithKline Recent Development Table 62. Pfizer Company Information Table 63. Pfizer Business Overview Table 64. Pfizer Alcoholic Liver Diseases Treatment Revenue (US$ Million) and Gross Margin (2021-2026) Table 65. Pfizer Alcoholic Liver Diseases Treatment Product Portfolio Table 66. Pfizer Recent Development Table 67. Novartis Company Information Table 68. Novartis Business Overview Table 69. Novartis Alcoholic Liver Diseases Treatment Revenue (US$ Million) and Gross Margin (2021-2026) Table 70. Novartis Alcoholic Liver Diseases Treatment Product Portfolio Table 71. Novartis Recent Development Table 72. Johnson & Johnson Services Company Information Table 73. Johnson & Johnson Services Business Overview Table 74. Johnson & Johnson Services Alcoholic Liver Diseases Treatment Revenue (US$ Million) and Gross Margin (2021-2026) Table 75. Johnson & Johnson Services Alcoholic Liver Diseases Treatment Product Portfolio Table 76. Johnson & Johnson Services Recent Development Table 77. Sanofi Company Information Table 78. Sanofi Business Overview Table 79. Sanofi Alcoholic Liver Diseases Treatment Revenue (US$ Million) and Gross Margin (2021-2026) Table 80. Sanofi Alcoholic Liver Diseases Treatment Product Portfolio Table 81. Sanofi Recent Development Table 82. Research Programs/Design for This Report Table 83. Authors List of This Report Table 84. Secondary Sources Table 85. Primary Sources List of Figures Figure 1. Alcoholic Liver Diseases Treatment Product Image Figure 2. Global Alcoholic Liver Diseases Treatment Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Alcoholic Liver Diseases Treatment Market Size (2021-2032) & (US$ Million) Figure 4. Global Alcoholic Liver Diseases Treatment Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Alcoholic Fatty Liver Disease Image Figure 8. Alcoholic Liver Hepatitis Image Figure 9. Others Image Figure 10. Global Alcoholic Liver Diseases Treatment Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 11. Global Alcoholic Liver Diseases Treatment Sales Value Share 2021 VS 2025 VS 2032 Figure 12. Global Alcoholic Liver Diseases Treatment Sales Value Share by Type (2021-2032) Figure 13. Hospital Pharmacies Image Figure 14. Drug Stores Image Figure 15. Online Pharmacies Image Figure 16. Retail Pharmacies Image Figure 17. Others Image Figure 18. Global Alcoholic Liver Diseases Treatment Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Alcoholic Liver Diseases Treatment Sales Value Share 2021 VS 2025 VS 2032 Figure 20. Global Alcoholic Liver Diseases Treatment Sales Value Share by Application (2021-2032) Figure 21. Global Alcoholic Liver Diseases Treatment Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 22. Global Alcoholic Liver Diseases Treatment Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 23. North America Alcoholic Liver Diseases Treatment Sales Value (2021-2032) & (US$ Million) Figure 24. North America Alcoholic Liver Diseases Treatment Sales Value Share by Country (%), 2025 VS 2032 Figure 25. Europe Alcoholic Liver Diseases Treatment Sales Value (2021-2032) & (US$ Million) Figure 26. Europe Alcoholic Liver Diseases Treatment Sales Value Share by Country (%), 2025 VS 2032 Figure 27. Asia-Pacific Alcoholic Liver Diseases Treatment Sales Value (2021-2032) & (US$ Million) Figure 28. Asia-Pacific Alcoholic Liver Diseases Treatment Sales Value Share by Country (%), 2025 VS 2032 Figure 29. South America Alcoholic Liver Diseases Treatment Sales Value (2021-2032) & (US$ Million) Figure 30. South America Alcoholic Liver Diseases Treatment Sales Value Share by Country (%), 2025 VS 2032 Figure 31. Middle East & Africa Alcoholic Liver Diseases Treatment Sales Value (2021-2032) & (US$ Million) Figure 32. Middle East & Africa Alcoholic Liver Diseases Treatment Sales Value Share by Country (%), 2025 VS 2032 Figure 33. USA Alcoholic Liver Diseases Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 34. USA Alcoholic Liver Diseases Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 35. USA Alcoholic Liver Diseases Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 36. Canada Alcoholic Liver Diseases Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 37. Canada Alcoholic Liver Diseases Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 38. Canada Alcoholic Liver Diseases Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 39. Mexico Alcoholic Liver Diseases Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. Mexico Alcoholic Liver Diseases Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. Mexico Alcoholic Liver Diseases Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. Germany Alcoholic Liver Diseases Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. Germany Alcoholic Liver Diseases Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. Germany Alcoholic Liver Diseases Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. France Alcoholic Liver Diseases Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. France Alcoholic Liver Diseases Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. France Alcoholic Liver Diseases Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. U.K. Alcoholic Liver Diseases Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. U.K. Alcoholic Liver Diseases Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. U.K. Alcoholic Liver Diseases Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Italy Alcoholic Liver Diseases Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Italy Alcoholic Liver Diseases Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Italy Alcoholic Liver Diseases Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. Spain Alcoholic Liver Diseases Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. Spain Alcoholic Liver Diseases Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. Spain Alcoholic Liver Diseases Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Russia Alcoholic Liver Diseases Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Russia Alcoholic Liver Diseases Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Russia Alcoholic Liver Diseases Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Netherlands Alcoholic Liver Diseases Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Netherlands Alcoholic Liver Diseases Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Netherlands Alcoholic Liver Diseases Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Nordic Countries Alcoholic Liver Diseases Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Nordic Countries Alcoholic Liver Diseases Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Nordic Countries Alcoholic Liver Diseases Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. China Alcoholic Liver Diseases Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. China Alcoholic Liver Diseases Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. China Alcoholic Liver Diseases Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Japan Alcoholic Liver Diseases Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Japan Alcoholic Liver Diseases Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Japan Alcoholic Liver Diseases Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. South Korea Alcoholic Liver Diseases Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. South Korea Alcoholic Liver Diseases Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. South Korea Alcoholic Liver Diseases Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. India Alcoholic Liver Diseases Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. India Alcoholic Liver Diseases Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. India Alcoholic Liver Diseases Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Australia Alcoholic Liver Diseases Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Australia Alcoholic Liver Diseases Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Australia Alcoholic Liver Diseases Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. Southeast Asia Alcoholic Liver Diseases Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. Southeast Asia Alcoholic Liver Diseases Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. Southeast Asia Alcoholic Liver Diseases Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Brazil Alcoholic Liver Diseases Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Brazil Alcoholic Liver Diseases Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Brazil Alcoholic Liver Diseases Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Argentina Alcoholic Liver Diseases Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Argentina Alcoholic Liver Diseases Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Argentina Alcoholic Liver Diseases Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Chile Alcoholic Liver Diseases Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Chile Alcoholic Liver Diseases Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Chile Alcoholic Liver Diseases Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Colombia Alcoholic Liver Diseases Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Colombia Alcoholic Liver Diseases Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Colombia Alcoholic Liver Diseases Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Peru Alcoholic Liver Diseases Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Peru Alcoholic Liver Diseases Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Peru Alcoholic Liver Diseases Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Saudi Arabia Alcoholic Liver Diseases Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Saudi Arabia Alcoholic Liver Diseases Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Saudi Arabia Alcoholic Liver Diseases Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Israel Alcoholic Liver Diseases Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Israel Alcoholic Liver Diseases Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Israel Alcoholic Liver Diseases Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. UAE Alcoholic Liver Diseases Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. UAE Alcoholic Liver Diseases Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. UAE Alcoholic Liver Diseases Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Turkey Alcoholic Liver Diseases Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Turkey Alcoholic Liver Diseases Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Turkey Alcoholic Liver Diseases Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Iran Alcoholic Liver Diseases Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Iran Alcoholic Liver Diseases Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Iran Alcoholic Liver Diseases Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Egypt Alcoholic Liver Diseases Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. Egypt Alcoholic Liver Diseases Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. Egypt Alcoholic Liver Diseases Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Years Considered Figure 118. Research Process Figure 119. Key Executives Interviewed

Scope & coverage.

Types
  • Alcoholic Fatty Liver Disease
  • Alcoholic Liver Hepatitis
  • Others
Applications
  • Hospital Pharmacies
  • Drug Stores
  • Online Pharmacies
  • Retail Pharmacies
  • Others
Companies covered
  • Roche Holding
  • Upsher-Smith Laboratories
  • Bayer
  • GlaxoSmithKline
  • Pfizer
  • Novartis
  • Johnson & Johnson Services
  • Sanofi

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Alcoholic Liver Diseases Treatment Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Alcoholic Liver Diseases Treatment Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Alcoholic Liver Diseases Treatment Market Dynamics
  1. 2.1 Alcoholic Liver Diseases Treatment Industry Trends
  2. 2.2 Alcoholic Liver Diseases Treatment Industry Drivers
  3. 2.3 Alcoholic Liver Diseases Treatment Industry Opportunities and Challenges
  4. 2.4 Alcoholic Liver Diseases Treatment Industry Restraints
3 Alcoholic Liver Diseases Treatment Market by Company
  1. 3.1 Global Alcoholic Liver Diseases Treatment Company Revenue Ranking in 2025
  2. 3.2 Global Alcoholic Liver Diseases Treatment Revenue by Company (2021-2026)
  3. 3.3 Global Alcoholic Liver Diseases Treatment Company Ranking (2024-2026)
  4. 3.4 Global Alcoholic Liver Diseases Treatment Company Manufacturing Base and Headquarters
  5. 3.5 Global Alcoholic Liver Diseases Treatment Company Product Type and Application
  6. 3.6 Global Alcoholic Liver Diseases Treatment Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Alcoholic Liver Diseases Treatment Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Alcoholic Liver Diseases Treatment Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Alcoholic Liver Diseases Treatment Market by Type
  1. 4.1 Alcoholic Liver Diseases Treatment Type Introduction
  2. 4.1.1 Alcoholic Fatty Liver Disease
  3. 4.1.2 Alcoholic Liver Hepatitis
  4. 4.1.3 Others
  5. 4.2 Global Alcoholic Liver Diseases Treatment Sales Value by Type
  6. 4.2.1 Global Alcoholic Liver Diseases Treatment Sales Value by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Alcoholic Liver Diseases Treatment Sales Value by Type (2021-2032)
  8. 4.2.3 Global Alcoholic Liver Diseases Treatment Sales Value Share by Type (2021-2032)
5 Alcoholic Liver Diseases Treatment Market by Application
  1. 5.1 Alcoholic Liver Diseases Treatment Application Introduction
  2. 5.1.1 Hospital Pharmacies
  3. 5.1.2 Drug Stores
  4. 5.1.3 Online Pharmacies
  5. 5.1.4 Retail Pharmacies
  6. 5.1.5 Others
  7. 5.2 Global Alcoholic Liver Diseases Treatment Sales Value by Application
  8. 5.2.1 Global Alcoholic Liver Diseases Treatment Sales Value by Application (2021 VS 2025 VS 2032)
  9. 5.2.2 Global Alcoholic Liver Diseases Treatment Sales Value by Application (2021-2032)
  10. 5.2.3 Global Alcoholic Liver Diseases Treatment Sales Value Share by Application (2021-2032)
6 Alcoholic Liver Diseases Treatment Regional Value Analysis
  1. 6.1 Global Alcoholic Liver Diseases Treatment Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Alcoholic Liver Diseases Treatment Sales Value by Region (2021-2032)
  3. 6.2.1 Global Alcoholic Liver Diseases Treatment Sales Value by Region: 2021-2026
  4. 6.2.2 Global Alcoholic Liver Diseases Treatment Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Alcoholic Liver Diseases Treatment Sales Value (2021-2032)
  7. 6.3.2 North America Alcoholic Liver Diseases Treatment Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Alcoholic Liver Diseases Treatment Sales Value (2021-2032)
  10. 6.4.2 Europe Alcoholic Liver Diseases Treatment Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Alcoholic Liver Diseases Treatment Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Alcoholic Liver Diseases Treatment Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Alcoholic Liver Diseases Treatment Sales Value (2021-2032)
  16. 6.6.2 South America Alcoholic Liver Diseases Treatment Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Alcoholic Liver Diseases Treatment Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Alcoholic Liver Diseases Treatment Sales Value Share by Country, 2025 VS 2032
7 Alcoholic Liver Diseases Treatment Country-level Value Analysis
  1. 7.1 Global Alcoholic Liver Diseases Treatment Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Alcoholic Liver Diseases Treatment Sales Value by Country (2021-2032)
  3. 7.2.1 Global Alcoholic Liver Diseases Treatment Sales Value by Country (2021-2026)
  4. 7.2.2 Global Alcoholic Liver Diseases Treatment Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Alcoholic Liver Diseases Treatment Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Alcoholic Liver Diseases Treatment Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Alcoholic Liver Diseases Treatment Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Alcoholic Liver Diseases Treatment Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Alcoholic Liver Diseases Treatment Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Alcoholic Liver Diseases Treatment Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Alcoholic Liver Diseases Treatment Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Alcoholic Liver Diseases Treatment Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Alcoholic Liver Diseases Treatment Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Alcoholic Liver Diseases Treatment Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Alcoholic Liver Diseases Treatment Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Alcoholic Liver Diseases Treatment Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Alcoholic Liver Diseases Treatment Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Alcoholic Liver Diseases Treatment Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Alcoholic Liver Diseases Treatment Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Alcoholic Liver Diseases Treatment Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Alcoholic Liver Diseases Treatment Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Alcoholic Liver Diseases Treatment Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Alcoholic Liver Diseases Treatment Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Alcoholic Liver Diseases Treatment Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Alcoholic Liver Diseases Treatment Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Alcoholic Liver Diseases Treatment Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Alcoholic Liver Diseases Treatment Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Alcoholic Liver Diseases Treatment Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Alcoholic Liver Diseases Treatment Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Alcoholic Liver Diseases Treatment Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Alcoholic Liver Diseases Treatment Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Alcoholic Liver Diseases Treatment Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Alcoholic Liver Diseases Treatment Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Alcoholic Liver Diseases Treatment Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Alcoholic Liver Diseases Treatment Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Alcoholic Liver Diseases Treatment Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Alcoholic Liver Diseases Treatment Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Alcoholic Liver Diseases Treatment Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Alcoholic Liver Diseases Treatment Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Alcoholic Liver Diseases Treatment Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Alcoholic Liver Diseases Treatment Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Alcoholic Liver Diseases Treatment Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Alcoholic Liver Diseases Treatment Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Alcoholic Liver Diseases Treatment Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Alcoholic Liver Diseases Treatment Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Alcoholic Liver Diseases Treatment Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Alcoholic Liver Diseases Treatment Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Alcoholic Liver Diseases Treatment Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Alcoholic Liver Diseases Treatment Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Alcoholic Liver Diseases Treatment Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Alcoholic Liver Diseases Treatment Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Alcoholic Liver Diseases Treatment Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Alcoholic Liver Diseases Treatment Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Alcoholic Liver Diseases Treatment Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Alcoholic Liver Diseases Treatment Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Alcoholic Liver Diseases Treatment Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Alcoholic Liver Diseases Treatment Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Alcoholic Liver Diseases Treatment Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Alcoholic Liver Diseases Treatment Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Alcoholic Liver Diseases Treatment Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Alcoholic Liver Diseases Treatment Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Alcoholic Liver Diseases Treatment Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Alcoholic Liver Diseases Treatment Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Alcoholic Liver Diseases Treatment Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Alcoholic Liver Diseases Treatment Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Alcoholic Liver Diseases Treatment Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Alcoholic Liver Diseases Treatment Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Alcoholic Liver Diseases Treatment Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Alcoholic Liver Diseases Treatment Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Alcoholic Liver Diseases Treatment Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Alcoholic Liver Diseases Treatment Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Alcoholic Liver Diseases Treatment Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Alcoholic Liver Diseases Treatment Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Alcoholic Liver Diseases Treatment Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Alcoholic Liver Diseases Treatment Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Alcoholic Liver Diseases Treatment Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Alcoholic Liver Diseases Treatment Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Alcoholic Liver Diseases Treatment Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Alcoholic Liver Diseases Treatment Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Alcoholic Liver Diseases Treatment Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Alcoholic Liver Diseases Treatment Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Alcoholic Liver Diseases Treatment Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Alcoholic Liver Diseases Treatment Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Alcoholic Liver Diseases Treatment Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Alcoholic Liver Diseases Treatment Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Alcoholic Liver Diseases Treatment Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Alcoholic Liver Diseases Treatment Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Alcoholic Liver Diseases Treatment Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Roche Holding
  2. 8.1.1 Roche Holding Company Information
  3. 8.1.2 Roche Holding Business Overview
  4. 8.1.3 Roche Holding Alcoholic Liver Diseases Treatment Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Roche Holding Alcoholic Liver Diseases Treatment Product Portfolio
  6. 8.1.5 Roche Holding Recent Developments
  7. 8.2 Upsher-Smith Laboratories
  8. 8.2.1 Upsher-Smith Laboratories Company Information
  9. 8.2.2 Upsher-Smith Laboratories Business Overview
  10. 8.2.3 Upsher-Smith Laboratories Alcoholic Liver Diseases Treatment Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Upsher-Smith Laboratories Alcoholic Liver Diseases Treatment Product Portfolio
  12. 8.2.5 Upsher-Smith Laboratories Recent Developments
  13. 8.3 Bayer
  14. 8.3.1 Bayer Company Information
  15. 8.3.2 Bayer Business Overview
  16. 8.3.3 Bayer Alcoholic Liver Diseases Treatment Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Bayer Alcoholic Liver Diseases Treatment Product Portfolio
  18. 8.3.5 Bayer Recent Developments
  19. 8.4 GlaxoSmithKline
  20. 8.4.1 GlaxoSmithKline Company Information
  21. 8.4.2 GlaxoSmithKline Business Overview
  22. 8.4.3 GlaxoSmithKline Alcoholic Liver Diseases Treatment Revenue and Gross Margin (2021-2026)
  23. 8.4.4 GlaxoSmithKline Alcoholic Liver Diseases Treatment Product Portfolio
  24. 8.4.5 GlaxoSmithKline Recent Developments
  25. 8.5 Pfizer
  26. 8.5.1 Pfizer Company Information
  27. 8.5.2 Pfizer Business Overview
  28. 8.5.3 Pfizer Alcoholic Liver Diseases Treatment Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Pfizer Alcoholic Liver Diseases Treatment Product Portfolio
  30. 8.5.5 Pfizer Recent Developments
  31. 8.6 Novartis
  32. 8.6.1 Novartis Company Information
  33. 8.6.2 Novartis Business Overview
  34. 8.6.3 Novartis Alcoholic Liver Diseases Treatment Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Novartis Alcoholic Liver Diseases Treatment Product Portfolio
  36. 8.6.5 Novartis Recent Developments
  37. 8.7 Johnson & Johnson Services
  38. 8.7.1 Johnson & Johnson Services Company Information
  39. 8.7.2 Johnson & Johnson Services Business Overview
  40. 8.7.3 Johnson & Johnson Services Alcoholic Liver Diseases Treatment Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Johnson & Johnson Services Alcoholic Liver Diseases Treatment Product Portfolio
  42. 8.7.5 Johnson & Johnson Services Recent Developments
  43. 8.8 Sanofi
  44. 8.8.1 Sanofi Company Information
  45. 8.8.2 Sanofi Business Overview
  46. 8.8.3 Sanofi Alcoholic Liver Diseases Treatment Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Sanofi Alcoholic Liver Diseases Treatment Product Portfolio
  48. 8.8.5 Sanofi Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst